Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|May 27, 2014
Estrogen signaling and the DNA damage response in hormone dependent breast cancersC Elizabeth CaldonMethodsx|November 14, 2019
Label free, quantitative single-cell fate tracking of time-lapse moviesC Elizabeth Caldon, Andrew BurgessCell Division|February 26, 2010
Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancerC Elizabeth Caldon, Elizabeth A MusgroveCell Cycle (Georgetown, Tex.)|May 18, 2010
Cell cycle proteins in epithelial cell differentiation: implications for breast cancerC Elizabeth Caldon, Robert L Sutherland, Elizabeth MusgroveJournal of Cellular and Molecular Medicine|September 22, 2025
Unmatched Cell Line Collections Are Not Optimal for Identification of PARP Inhibitor Response and Drug SynergiesZoe Phan, Kristine J Fernandez, C Elizabeth CaldonPharmacological Research|September 17, 2023
DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic reviewZoe Phan, Caroline E Ford, C Elizabeth CaldonCell Cycle (Georgetown, Tex.)|January 18, 2013
Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Robert L Sutherland, et al.Journal of Cellular Biochemistry|November 4, 2005
Cell cycle control in breast cancer cellsC Elizabeth Caldon, Roger J Daly, Robert L Sutherland, et al.Nature Reviews. Cancer|July 8, 2011
Cyclin D as a therapeutic target in cancerElizabeth A Musgrove, C Elizabeth Caldon, Jane Barraclough, et al.Endocrine-Related Cancer|November 4, 2018
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancerNeil Portman, Sarah Alexandrou, Emma Carson, et al.Pageof 5